105 related articles for article (PubMed ID: 8026554)
1. Effects of nefiracetam on drug-induced impairment of latent learning in mice in a water finding task.
Nabeshima T; Nakayama S; Ichihara K; Yamada K; Shiotani T; Hasegawa T
Eur J Pharmacol; 1994 Apr; 255(1-3):57-65. PubMed ID: 8026554
[TBL] [Abstract][Full Text] [Related]
2. Nefiracetam (DM-9384) reverses apomorphine-induced amnesia of a passive avoidance response: delayed emergence of the memory retention effects.
Doyle E; O'Boyle KM; Shiotani T; Regan CM
Neurochem Res; 1996 Jun; 21(6):649-52. PubMed ID: 8829135
[TBL] [Abstract][Full Text] [Related]
3. Effects of nefiracetam on amnesia animal models with neuronal dysfunctions.
Hiramatsu M; Shiotani T; Kameyama T; Nabeshima T
Behav Brain Res; 1997 Feb; 83(1-2):107-15. PubMed ID: 9062668
[TBL] [Abstract][Full Text] [Related]
4. Nefiracetam ameliorates associative learning impairment in the scopolamine-injected older rabbit.
Pak J; Green J; Heifets B; Pak M; Woodruff-Pak D
Med Sci Monit; 2002 Apr; 8(4):BR105-12. PubMed ID: 11951055
[TBL] [Abstract][Full Text] [Related]
5. General pharmacological profile of the new cognition-enhancing agent nefiracetam.
Kitano Y; Makino M; Usui C; Takasuna K; Kasai Y; Hirohashi M; Tamura K; Takayama S; Kojima H; Iizuka H
Arzneimittelforschung; 1994 Feb; 44(2A):199-210. PubMed ID: 8018090
[TBL] [Abstract][Full Text] [Related]
6. Possible involvement of the activation of voltage-sensitive calcium channels in the ameliorating effects of nefiracetam on scopolamine-induced impairment of performance in a passive avoidance task.
Yamada K; Nakayama S; Shiotani T; Hasegawa T; Nabeshima T
J Pharmacol Exp Ther; 1994 Sep; 270(3):881-92. PubMed ID: 7932200
[TBL] [Abstract][Full Text] [Related]
7. Cellular mechanisms underlying cognition-enhancing actions of nefiracetam (DM-9384).
Yoshii M; Watabe S; Sakurai T; Shiotani T
Behav Brain Res; 1997 Feb; 83(1-2):185-8. PubMed ID: 9062681
[TBL] [Abstract][Full Text] [Related]
8. Mecamylamine- or scopolamine-induced learning impairment: ameliorated by nefiracetam.
Woodruff-Pak DS; Hinchliffe RM
Psychopharmacology (Berl); 1997 May; 131(2):130-9. PubMed ID: 9201800
[TBL] [Abstract][Full Text] [Related]
9. Nefiracetam attenuates methamphetamine-induced discriminative stimulus effects in rats.
Yan Y; Mizuno T; Nitta A; Yamada K; Nabeshima T
Ann N Y Acad Sci; 2004 Oct; 1025():274-8. PubMed ID: 15542727
[TBL] [Abstract][Full Text] [Related]
10. Nefiracetam (DM-9384) preserves hippocampal neural cell adhesion molecule-mediated memory consolidation processes during scopolamine disruption of passive avoidance training in the rat.
Doyle E; Regan CM; Shiotani T
J Neurochem; 1993 Jul; 61(1):266-72. PubMed ID: 8515273
[TBL] [Abstract][Full Text] [Related]
11. Effects of the subacute administration of nefiracetam on abnormal behavior in aged rats.
Hasegawa M; Nakayama S; Kinoshita H; Amano M; Yamada K; Hasegawa T; Nabeshima T
Behav Brain Res; 1996 Aug; 78(2):93-100. PubMed ID: 8864041
[TBL] [Abstract][Full Text] [Related]
12. Effects of DM-9384, a pyrrolidone derivative, on alcohol- and chlordiazepoxide-induced amnesia in mice.
Nabeshima T; Tohyama K; Kameyama T
Pharmacol Biochem Behav; 1990 Jun; 36(2):233-6. PubMed ID: 2113296
[TBL] [Abstract][Full Text] [Related]
13. Effects of nefiracetam, DM-9384 on amnesia and decrease in choline acetyltransferase activity induced by cycloheximide.
Shiotani T; Tohyama K; Murase K; Ishihara S; Kameyama T; Yamasaki T; Hatanaka S; Kojima H; Takasu Y; Nabeshima T
J Neural Transm Gen Sect; 1992; 90(2):103-11. PubMed ID: 1463591
[TBL] [Abstract][Full Text] [Related]
14. Nonopioid and neuropathy-specific analgesic action of the nootropic drug nefiracetam in mice.
Rashid MH; Ueda H
J Pharmacol Exp Ther; 2002 Oct; 303(1):226-31. PubMed ID: 12235255
[TBL] [Abstract][Full Text] [Related]
15. Improvement of impaired brain monoamine metabolism by the cognition-enhancing agent nefiracetam after microsphere-induced cerebral embolism in rats.
Watabe S; Taniguchi K; Kojima H
Arzneimittelforschung; 1994 Feb; 44(2A):195-8. PubMed ID: 7517140
[TBL] [Abstract][Full Text] [Related]
16. Effects of intracranial infusions of chlordiazepoxide on spatial learning in the Morris water maze. II. Neuropharmacological specificity.
McNamara RK; Skelton RW
Behav Brain Res; 1993 Dec; 59(1-2):193-204. PubMed ID: 8155287
[TBL] [Abstract][Full Text] [Related]
17. Involvement of the cholinergic system in the effects of nefiracetam (DM-9384) on carbon monoxide (CO)-induced acute and delayed amnesia.
Hiramatsu M; Koide T; Ishihara S; Shiotani T; Kameyama T; Nabeshima T
Eur J Pharmacol; 1992 Jun; 216(2):279-85. PubMed ID: 1397012
[TBL] [Abstract][Full Text] [Related]
18. Effects of nefiracetam (DM-9384), a pyrrolidone derivative, on brain monoamine systems.
Luthman J; Lindqvist E; Kojima H; Shiotani T; Tanaka M; Tachizawa H; Olson L
Arch Int Pharmacodyn Ther; 1994; 328(2):125-44. PubMed ID: 7535993
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of neuronal calcium channel currents by the nootropic agent, nefiracetam (DM-9384), in NG108-15 cells.
Yoshii M; Watabe S
Brain Res; 1994 Apr; 642(1-2):123-31. PubMed ID: 8032872
[TBL] [Abstract][Full Text] [Related]
20. Cholinergic modulation of spatial learning in mice in a Morris-type water maze.
Lamberty Y; Gower AJ
Arch Int Pharmacodyn Ther; 1991; 309():5-19. PubMed ID: 1888229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
